Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT
Clinical trial NCT06061848 · RECRUITING
Trial details
- NCT number
- NCT06061848
- Sponsor
- Lars Olaf Cardell
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2030-12-28
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.